These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 18936783)

  • 1. Enhancement of memory function in aged mice by a novel derivative of xanomeline.
    Cui Y; Wang D; Si W; Lv W; Niu Y; Lei X; Hu Y; Cao X
    Cell Res; 2008 Nov; 18(11):1151-3. PubMed ID: 18936783
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of receptor protein and membrane lipids in xanomeline wash-resistant binding to muscarinic M1 receptors.
    Jakubík J; Tucek S; El-Fakahany EE
    J Pharmacol Exp Ther; 2004 Jan; 308(1):105-10. PubMed ID: 14569060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of xanomeline analogs--probing the wash-resistant phenomenon at the M1 muscarinic acetylcholine receptor.
    Kane BE; Grant MK; El-Fakahany EE; Ferguson DM
    Bioorg Med Chem; 2008 Feb; 16(3):1376-92. PubMed ID: 17977730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel derivative of xanomeline improves fear cognition in aged mice.
    Si W; Zhang X; Niu Y; Yu H; Lei X; Chen H; Cao X
    Neurosci Lett; 2010 Apr; 473(2):115-9. PubMed ID: 20178835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term changes in the muscarinic M1 receptor induced by instantaneous formation of wash-resistant xanomeline-receptor complex.
    De Lorme KC; Grant MK; Noetzel MJ; Polson SB; El-Fakahany EE
    J Pharmacol Exp Ther; 2007 Dec; 323(3):868-76. PubMed ID: 17855477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in kinetics of xanomeline binding and selectivity of activation of G proteins at M(1) and M(2) muscarinic acetylcholine receptors.
    Jakubík J; El-Fakahany EE; Dolezal V
    Mol Pharmacol; 2006 Aug; 70(2):656-66. PubMed ID: 16675658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of amphetamine-induced activity by the non-selective muscarinic receptor agonist, xanomeline, is absent in muscarinic M4 receptor knockout mice and attenuated in muscarinic M1 receptor knockout mice.
    Woolley ML; Carter HJ; Gartlon JE; Watson JM; Dawson LA
    Eur J Pharmacol; 2009 Jan; 603(1-3):147-9. PubMed ID: 19111716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hybrid molecules from xanomeline and tacrine: enhanced tacrine actions on cholinesterases and muscarinic M1 receptors.
    Fang L; Jumpertz S; Zhang Y; Appenroth D; Fleck C; Mohr K; Tränkle C; Decker M
    J Med Chem; 2010 Mar; 53(5):2094-103. PubMed ID: 20158205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-affinity M(2) receptor binding state mediates mouse atrial bradycardia: comparative effects of carbamylcholine and the M(1) receptor agonists sabcomeline and xanomeline.
    Stengel PW; Cohen ML
    J Pharmacol Exp Ther; 2001 Mar; 296(3):818-24. PubMed ID: 11181912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological characterization of 1-methyl-1,2,5,6-tetrahydropyridyl-1,2,5-thiadiazole derivatives as muscarinic agonists for the treatment of neurological disorders.
    Cao Y; Zhang M; Wu C; Lee S; Wroblewski ME; Whipple T; Nagy PI; Takács-Novák K; Balázs A; Torös S; Messer WS
    J Med Chem; 2003 Sep; 46(20):4273-86. PubMed ID: 13678406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent binding and functional antagonism by xanomeline at the muscarinic M5 receptor.
    Grant MK; El-Fakahany EE
    J Pharmacol Exp Ther; 2005 Oct; 315(1):313-9. PubMed ID: 16002459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term wash-resistant effects of brief interaction of xanomeline at the M1 muscarinic receptor.
    De Lorme KC; Sikorski KL; Grant MK; El-Fakahany EE
    Neurosci Lett; 2006 Dec; 410(1):11-4. PubMed ID: 17052840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel persistent activation of muscarinic M1 receptors by xanomeline.
    Christopoulos A; El-Fakahany EE
    Eur J Pharmacol; 1997 Sep; 334(1):R3-4. PubMed ID: 9346340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of side chains on 1,2,5-thiadiazole-azacycles optimal for muscarinic m1 receptor activation.
    Sauerberg P; Jeppesen L; Olesen PH; Sheardown MJ; Fink-Jensen A; Rasmussen T; Rimvall K; Shannon HE; Bymaster FP; DeLapp NW; Calligaro DO; Ward JS; Whitesitt CA; Thomsen C
    Bioorg Med Chem Lett; 1998 Oct; 8(20):2897-902. PubMed ID: 9873644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological evaluation of the long-term effects of xanomeline on the M(1) muscarinic acetylcholine receptor.
    Grant MK; Noetzel MJ; De Lorme KC; Jakubík J; Doležal V; El-Fakahany EE
    PLoS One; 2010 Dec; 5(12):e15722. PubMed ID: 21203415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Striatal, Hippocampal, and Cortical Networks Are Differentially Responsive to the M4- and M1-Muscarinic Acetylcholine Receptor Mediated Effects of Xanomeline.
    Thorn CA; Moon J; Bourbonais CA; Harms J; Edgerton JR; Stark E; Steyn SJ; Butter CR; Lazzaro JT; O'Connor RE; Popiolek M
    ACS Chem Neurosci; 2019 Mar; 10(3):1753-1764. PubMed ID: 30480428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacrine-xanomeline and tacrine-iperoxo hybrid ligands: Synthesis and biological evaluation at acetylcholinesterase and M
    Maspero M; Volpato D; Cirillo D; Yuan Chen N; Messerer R; Sotriffer C; De Amici M; Holzgrabe U; Dallanoce C
    Bioorg Chem; 2020 Mar; 96():103633. PubMed ID: 32032848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wash-resistantly bound xanomeline inhibits acetylcholine release by persistent activation of presynaptic M(2) and M(4) muscarinic receptors in rat brain.
    Machová E; Jakubík J; El-Fakahany EE; Dolezal V
    J Pharmacol Exp Ther; 2007 Jul; 322(1):316-23. PubMed ID: 17446301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The M1/M4 preferring agonist xanomeline is analgesic in rodent models of chronic inflammatory and neuropathic pain via central site of action.
    Martino G; Puma C; Yu XH; Gilbert AK; Coupal M; Markoglou N; McIntosh FS; Perkins MN; Laird JMA
    Pain; 2011 Dec; 152(12):2852-2860. PubMed ID: 22018972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance and prospects for design of selective muscarinic agonists.
    Jakubík J; Michal P; Machová E; Dolezal V
    Physiol Res; 2008; 57 Suppl 3():S39-S47. PubMed ID: 18481916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.